Literature DB >> 25129240

SNCA variants rs2736990 and rs356220 as risk factors for Parkinson's disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.

Xiao Yan Guo1, Yong Ping Chen1, Wei Song1, Bi Zhao1, Bei Cao1, Qian Qian Wei1, Ru Wei Ou1, Yuan Yang2, Li Xing Yuan3, Hui-Fang Shang4.   

Abstract

Previous studies found that polymorphisms rs2736990 and rs356220 in the alpha-synuclein (SNCA) gene increase the risk for Parkinson's disease (PD) in a Caucasian population. In consideration of the overlapping of clinical manifestations and pathologic characteristics among PD, amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA), the possible associations of these 2 polymorphisms and 3 neurodegenerative diseases were studied in the Chinese population. A total of 1011 PD, 778 sporadic ALS (SALS), 264 MSA patients, and 721 healthy controls (HCs) were studied. All subjects were genotyped for the 2 polymorphisms using polymerase chain reaction and direct sequencing. Significant differences in the genotype frequencies (p = 0.0188 and 0.0064, respectively) and minor allele frequencies (MAFs) (p = 0.0065 and 0.0095, respectively) of rs2736990 and rs356220 were observed between the PD patients and HCs. Moreover, significant differences were found between the early-onset PD patients (<50 years) and matched controls but not in the late-onset PD patients (≥50 years). However, no differences were observed between subgroups with regard to clinical features, such as sex, onset symptoms (tremor or rigidity), cognition (normal or abnormal), and anxiety and depression (presence or absence). No significant differences were found in the genotype frequencies and MAFs of these 2 single-nucleotide polymorphisms between SALS patients and HCs and between MSA patients and HCs. No significant differences were found between subgroups with regard to the clinical presentation of SALS and MSA. Our results show that rs2736990 and rs356220 in SNCA decreased the risk for PD in a Chinese population. These candidate polymorphisms were unlikely to be the causes of SALS and MSA in this population.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Multiple system atrophy; Parkinson’s disease; Polymorphisms; SNCA; rs2736990; rs356220

Mesh:

Substances:

Year:  2014        PMID: 25129240     DOI: 10.1016/j.neurobiolaging.2014.07.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

1.  Analysis and meta-analysis of five polymorphisms of the LINGO1 and LINGO2 genes in Parkinson's disease and multiple system atrophy in a Chinese population.

Authors:  YongPing Chen; Bei Cao; Jing Yang; QianQian Wei; Ru Wei Ou; Bi Zhao; Wei Song; XiaoYan Guo; HuiFang Shang
Journal:  J Neurol       Date:  2015-08-08       Impact factor: 4.849

2.  The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.

Authors:  Neda Shahmohammadibeni; Simin Rahimi-Aliabadi; Javad Jamshidi; Babak Emamalizadeh; Hossein Ali Shahmohammadibeni; Alireza Zare Bidoki; Haleh Akhavan-Niaki; Hajar Eftekhari; Shokoufeh Abdollahi; Mahmoud Shekari Khaniani; Mahnaz Shahmohammadibeni; Atena Fazeli; Marzieh Motallebi; Shaghayegh Taghavi; Azadeh Ahmadifard; Amir Ehtesham Shafiei Zarneh; Monavvar Andarva; Tahereh Dadkhah; Ehteram Khademi; Elham Alehabib; Mahnoosh Rahimi; Abbas Tafakhori; Minoo Atakhorrami; Hossein Darvish
Journal:  Neurol Sci       Date:  2016-01-05       Impact factor: 3.307

3.  SNCA Gene Polymorphism may Contribute to an Increased Risk of Alzheimer's Disease.

Authors:  Quanbao Wang; Qian Tian; Xiaojie Song; Yunyong Liu; Wei Li
Journal:  J Clin Lab Anal       Date:  2016-05-17       Impact factor: 2.352

4.  Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy.

Authors:  Anna I Wernick; Ronald L Walton; Alexandra I Soto-Beasley; Shunsuke Koga; Michael G Heckman; Rebecca R Valentino; Lukasz M Milanowski; Dorota Hoffman-Zacharska; Dariusz Koziorowski; Anhar Hassan; Ryan J Uitti; William P Cheshire; Wolfgang Singer; Zbigniew K Wszolek; Dennis W Dickson; Phillip A Low; Owen A Ross
Journal:  Clin Auton Res       Date:  2021-01-27       Impact factor: 5.625

5.  Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.

Authors:  YongPing Chen; Qian-Qian Wei; RuWei Ou; Bei Cao; XuePing Chen; Bi Zhao; XiaoYan Guo; Yuan Yang; Ke Chen; Ying Wu; Wei Song; Hui-Fang Shang
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 6.  Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders.

Authors:  Sonja W Scholz; Jose Bras
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

Review 7.  Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review.

Authors:  Clarissa Loureiro das Chagas Campêlo; Regina Helena Silva
Journal:  Parkinsons Dis       Date:  2017-07-11

8.  A Comprehensive Analysis of the Association Between SNCA Polymorphisms and the Risk of Parkinson's Disease.

Authors:  Yuan Zhang; Li Shu; Qiying Sun; Hongxu Pan; Jifeng Guo; Beisha Tang
Journal:  Front Mol Neurosci       Date:  2018-10-25       Impact factor: 5.639

Review 9.  Multiple system atrophy: the application of genetics in understanding etiology.

Authors:  Monica Federoff; Lucia V Schottlaender; Henry Houlden; Andrew Singleton
Journal:  Clin Auton Res       Date:  2015-02-17       Impact factor: 4.435

10.  Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.

Authors:  Clarissa L C Campêlo; Fernanda C Cagni; Diego de Siqueira Figueredo; Luiz G Oliveira; Antônio B Silva-Neto; Priscila T Macêdo; José R Santos; Geison S Izídio; Alessandra M Ribeiro; Tiago G de Andrade; Clécio de Oliveira Godeiro; Regina H Silva
Journal:  Front Aging Neurosci       Date:  2017-06-20       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.